BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12889910)

  • 1. Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.
    Hale KJ; Domostoj MM; Tocher DA; Irving E; Scheinmann F
    Org Lett; 2003 Aug; 5(16):2927-30. PubMed ID: 12889910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.
    Domostoj MM; Irving E; Scheinmann F; Hale KJ
    Org Lett; 2004 Jul; 6(15):2615-8. PubMed ID: 15255704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of the beta-catenin inhibitor, (-)-agelastatin A: a second-generation approach based on radical aminobromination.
    Yoshimitsu T; Ino T; Futamura N; Kamon T; Tanaka T
    Org Lett; 2009 Aug; 11(15):3402-5. PubMed ID: 19588910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of (+/-)-agelastatin A, a potent inhibitor of osteopontin-mediated neoplastic transformations.
    Dickson DP; Wardrop DJ
    Org Lett; 2009 Mar; 11(6):1341-4. PubMed ID: 19228041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of (-)-agelastatin A by [3.3] sigmatropic rearrangement of allyl cyanate.
    Ichikawa Y; Yamaoka T; Nakano K; Kotsuki H
    Org Lett; 2007 Aug; 9(16):2989-92. PubMed ID: 17602639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric total synthesis of (-)-agelastatin a using sulfinimine (N-sulfinyl imine) derived methodologies.
    Davis FA; Deng J
    Org Lett; 2005 Feb; 7(4):621-3. PubMed ID: 15704909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A short total synthesis of the marine sponge pyrrole-2-aminoimidazole alkaloid (±)-agelastatin A.
    Duspara PA; Batey RA
    Angew Chem Int Ed Engl; 2013 Oct; 52(41):10862-6. PubMed ID: 24038621
    [No Abstract]   [Full Text] [Related]  

  • 8. Asymmetric aziridination of cyclic enones using chiral diamine catalysts and its application to the total synthesis of (-)-agelastatin A.
    Menjo Y; Hamajima A; Sasaki N; Hamada Y
    Org Lett; 2011 Nov; 13(21):5744-7. PubMed ID: 21966984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of an anticancer norsesquiterpene alkaloid isolated from the fungus Flammulina velutipes.
    Kashinath K; Jadhav PD; Reddy DS
    Org Biomol Chem; 2014 Jun; 12(24):4098-103. PubMed ID: 24769797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total synthesis of (-)-agelastatin A.
    Yoshimitsu T; Ino T; Tanaka T
    Org Lett; 2008 Dec; 10(23):5457-60. PubMed ID: 19006318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereocontrolled synthesis of vicinal diamines by organocatalytic asymmetric Mannich reaction of N-protected aminoacetaldehydes: formal synthesis of (-)-agelastatin A.
    Kano T; Sakamoto R; Akakura M; Maruoka K
    J Am Chem Soc; 2012 May; 134(17):7516-20. PubMed ID: 22486203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.
    Antropow AH; Xu K; Buchsbaum RJ; Movassaghi M
    J Org Chem; 2017 Aug; 82(15):7720-7731. PubMed ID: 28696693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin A.
    Trost BM; Dong G
    Chemistry; 2009 Jul; 15(28):6910-9. PubMed ID: 19533707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.
    Wehn PM; Du Bois J
    Angew Chem Int Ed Engl; 2009; 48(21):3802-5. PubMed ID: 19378315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studies.
    Stout EP; Choi MY; Castro JE; Molinski TF
    J Med Chem; 2014 Jun; 57(12):5085-93. PubMed ID: 24673739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activity of all known (-)-agelastatin alkaloids.
    Han S; Siegel DS; Morrison KC; Hergenrother PJ; Movassaghi M
    J Org Chem; 2013 Dec; 78(23):11970-84. PubMed ID: 24152243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compounds, compositions, and methods of agelastatin alkaloids: patent evaluation of WO2015042239 (A1).
    Yoshimitsu T; Tun HW
    Expert Opin Ther Pat; 2017 Feb; 27(2):113-119. PubMed ID: 28056571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The
    D'Ambrosio M
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3β.
    Atilla-Gokcumen GE; Di Costanzo L; Meggers E
    J Biol Inorg Chem; 2011 Jan; 16(1):45-50. PubMed ID: 20821241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aziridine carboxylate from D-glucose: synthesis of polyhydroxylated piperidine, pyrrolidine alkaloids and study of their glycosidase inhibition.
    Dhavale DD; Kumar KS; Chaudhari VD; Sharma T; Sabharwal SG; Prakashareddy J
    Org Biomol Chem; 2005 Oct; 3(20):3720-6. PubMed ID: 16211108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.